BALAXI PHARMACEUTICALS LIMITED Cash Flow Reinvestment Rate

Latest as of September 2025: 0.83x

BALAXI PHARMACEUTICALS LIMITED cash flow reinvestment rate. BALAXI PHARMACEUTICALS LIMITED (BALAXI) has a Cash Flow Reinvestment Rate of 0.83x as of September 2025, reinvesting Rs123.88 Million (capex Rs123.88 Million ) from operating cash flow of Rs149.66 Million. See BALAXI PHARMACEUTICALS LIMITED leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.

Reinvestment Rate

0.83x
(Capex + Investments) / Operating CF

Total Reinvested

Rs123.88 Million
Capex + Investments

Operating Cash Flow

Rs149.66 Million
INR

Capital Expenditures

Rs123.88 Million
INR

Cash Flow Reinvestment Rate of BALAXI PHARMACEUTICALS LIMITED (2013–2024)

Cash flow reinvestment rate of BALAXI PHARMACEUTICALS LIMITED from 2013 to 2024. Historical reinvestment intensity for BALAXI PHARMACEUTICALS LIMITED across 6 annual periods. Explore BALAXI cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.

BALAXI PHARMACEUTICALS LIMITED Cash Flow Reinvestment Rate by Year (2013–2024)

BALAXI PHARMACEUTICALS LIMITED cash flow reinvestment rate by year from 2013 to 2024. Year-by-year capital reinvestment analysis for BALAXI PHARMACEUTICALS LIMITED. For the full cash flow conversion analysis, see BALAXI cash flow metrics.

Year Reinvestment Rate Total Reinvested (INR) Operating CF Capex YoY Change
2024 0.54x Rs26.16 Million Rs48.66 Million Rs15.69 Million ▼ -87.2%
2023 4.20x Rs255.45 Million Rs60.75 Million Rs149.80 Million ▲ +366.7%
2022 0.90x Rs307.61 Million Rs341.44 Million Rs273.44 Million ▼ -100.0%
2021 1926.71x Rs59.73 Million Rs31.00K Rs25.56 Million ▲ +13694722.6%
2015 0.01x Rs29.72K Rs2.11 Million Rs29.72K —
2013 0.00x Rs0.00 Rs3.25 Million Rs0.00 —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow